AGM and Interim Management Statement

Tate & Lyle PLC
                  

CHAIRMAN'S AGM AND INTERIM MANAGEMENT STATEMENT

At the Annual General Meeting of Tate & Lyle PLC to be held in London today, Sir
David Lees, Chairman, will make the following statement:

Trading Update

Trading in the current financial year has started in line with our expectations
with total operating profit at constant exchange rates for the first three
months similar to the prior year.

Profit from continuing operations* at constant exchange rates was below the
exceptionally strong first quarter of the prior year.

Sales of SPLENDA(R) Sucralose in the first quarter were ahead of the comparator
period with customer de-stocking thus far having less of an effect than
anticipated. The predicted increase in fixed costs arising from the start of
production at the new Singapore facility impacted profits which nevertheless for
the quarter were ahead of last year. At this stage of the year we continue to
expect satisfactory sales growth for the year but that any increase in operating
profit is likely to be modest and second half weighted.

Profits from continuing operations* in the Ingredients divisions for the quarter
were somewhat below last year. Whilst the main operations at Ingredients,
Americas were ahead of the prior year, this was more than offset by lower
returns from ethanol and citric acid. Profit from the continuing operations* in
Ingredients, Europe was better despite higher raw material prices. While corn
prices in America have reduced following US Department of Agriculture forecasts
of a good harvest this year, prices for both wheat and corn in Europe have
significantly increased. European sales prices will be increased where possible
in order to offset these higher costs.

Profits from continuing operations in the Sugar division as a whole were
significantly lower than the comparative period principally due to a return to a
more normal level of profitability in sugar trading and continuing difficult
market conditions in the EU and Vietnam.

The Group generated positive free cash flow for the three months to 30 June
2007.

There have been no material changes to the Groups net assets since 31 March
2007.

Transaction Update

In the last three months, certain previously announced transactions have been
completed or progressed as contributors to our strategy of creating a stronger
value added business building on our low cost commodity base whilst, at the same
time, reducing the impact of our exposure to volatile markets.

The sale of Tate & Lyle Canada Ltd for a net consideration of £131 million was
completed on 21 April 2007. The profit on disposal was £55 million, subject to
closing adjustments, and will be reflected as an exceptional item in the results
for the first half year.

On 15 June 2007 we completed the acquisition of an 80% holding in German
specialty food ingredients group G. C. Hahn & Co for a total cash consideration
of £78 million. This investment will broaden both our value added product
offering and our customer base.

In early May we announced that we were in exclusive discussions with Syral SAS
(a subsidiary of Tereos of France) for the disposal of our interest in the
facilities of Food & Industrial Ingredients, Europe in the UK, Belgium, France,
Spain and Italy. We announced today that we have signed an agreement for the
disposal of these facilities for a consideration of EUR 310 million (£209
million), subject to closing adjustments. The disposal is expected to result in
an exceptional loss of approximately £20 million after restructuring costs. The
transaction, which is subject to antitrust approval, will reduce the impact of
our exposure to volatile markets and to the EU sugar regime.

The disposal of our interest in Occidente, our joint venture cane sugar producer
in Mexico, is being explored with a number of interested parties. At 31 March
2007 Tate & Lyle's share of the net operating assets of Occidente was £42
million. Tate & Lyle's share of the operating profit for the year to 31 March
2007 was £6 million. Further announcements on this transaction will be made as
appropriate.

Outlook

As advised in our preliminary results statement we regard 2007/8 as a year of
transition. The development of our core Ingredients and Sucralose businesses is
progressing satisfactorily and our expectations for these businesses have not
changed.

As described above, we are experiencing market weakness affecting our sugar,
ethanol and citric acid businesses and a challenging European cereals market. In
addition, the strength of sterling is likely to adversely impact our reported
results and as a consequence, our current expectation of continuing operations*
results for the year to

31 March 2008 is slightly lower than when we announced our results for the
previous financial year in May.

Taxation

We have made good progress in improving our tax management and will be
implementing revised financing arrangements over the next few months. The part
year impact in 2007/08 is likely to be modest and is dependent on expected
regulatory approval. The anticipated full-year saving in 2008/09 should be
substantial.

Return of Capital to Shareholders

Subject to the renewal of authority from shareholders at today's AGM, the Board
intends to commence an on-market share buy back programme for an amount of up to

£275 million. In deciding on the quantum of the buy back programme, the Board
took into consideration the future capital expenditure requirements of the
business, discussions with the credit rating agencies and the importance we
attach to maintaining our investment grade rating.
                                                                                                                                                                                                        announced today and referred to above.

-0-
*T
For more information contact Tate & Lyle PLC:

Mark Robinson, Director of Investor Relations
Tel: [phone] or Mobile: [phone]

Ferne Hudson, Head of Media and Public Relations
Tel: [phone] or Mobile: [phone]
*T

About Tate & Lyle:

Tate & Lyle is a world leading manufacturer of renewable food and industrial
ingredients. It uses innovative technology to transform corn, wheat and sugar
into value-added ingredients for customers in the food, beverage,
pharmaceutical, cosmetic, paper, packaging and building industries. The Company
is a leader in cereal sweeteners and starches, sugar refining, value added food
and industrial ingredients, and citric acid. Tate & Lyle is the world number-one
in industrial starches and is the sole manufacturer of SPLENDA(R) Sucralose.

Headquartered in London, Tate & Lyle is listed on the London Stock Exchange
under the symbol TATE.L. In the US its ADRs trade under TATYY. The Company
operates more than 60 production facilities in 23 countries, throughout Europe,
the Americas and South East Asia. In the year to 31 March 2007, it employed
6,900 people in its subsidiaries with a further 2,300 employed in joint
ventures. Sales in the year to 31 March 2007 totalled £4.0 billion. Additional
information can be found on http://www.tateandlyle.com.

SPLENDA(R) is a trademark of McNeil Nutritionals, LLC